Diabetic Retinopathy
JKAEI is a member of the Diabetic Clinical Research Network (DRCR). This network is funded by the National Institutes of Health and through private industry. There are approximately 150 participating sites in both private practice and academic centers. We are one of the charter members of this organization and one of the top ten recruitment sites in the country. The various sites submit data via the internet to the coordinating center. In this manner, data from numerous sites can be obtained and rapidly analyzed in order to carry out studies quickly and efficiently. The DRCR has garnered praise from the National Institutes of Health and private industry for its performance to date. It is the goal ofthe DRCR that virtually all patients with diabetic retinopathy will be able to participate in a clinical trial. Already, the results of the network’s initial clinical trials are changing for the better the way we treat patients with diabetic retinopathy.
Recruitment is ongoing for the following studies sponsored by the Diabetic Clinical Reserach Network:
Evaluation of Vitrectomy for Diabetic Macular Edema
Intravitreal Ranibizumab or Triamcinolone Acetonide in Combination with Laser Photocoagulation for Diabetic Macular Edema
The Course of Response to Focal Photocoagulation for Diabetic Macular Edema
Recruitment is ongoing for a study sponsored by Alimera Sciences
Fluocinolone Acetonide in Diabetic Macular Edema Assesing the efficacy of an implantable sustained delivery device
Recruitment will begin soon for the following studies:
VEGF-trap for the treatment of wet macular degeneration
Cataract Surgery and Diabetic Macular Edema - protocol in development; recruitment expected to begin in Fall 2007 |
